Lung Cancer Vaccine Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Lung Cancer Vaccine in global, including the following market information:
Global Lung Cancer Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lung Cancer Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Lung Cancer Vaccine companies in 2021 (%)
The global Lung Cancer Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Subunit Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Vaccine include GlaxoSmithKline, Oncothyreon Incorporation, Eli Lily, ImClone Systems, Boehringer Ingelheim, Merck, Ono Pharmaceutical and CureVac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Cancer Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lung Cancer Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Lung Cancer Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Lung Cancer Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lung Cancer Vaccine revenues share in global market, 2021 (%)
Key companies Lung Cancer Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Lung Cancer Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Lung Cancer Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lung Cancer Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Lung Cancer Vaccine companies in 2021 (%)
The global Lung Cancer Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Subunit Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Vaccine include GlaxoSmithKline, Oncothyreon Incorporation, Eli Lily, ImClone Systems, Boehringer Ingelheim, Merck, Ono Pharmaceutical and CureVac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung Cancer Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Lung Cancer Vaccine Market Segment Percentages, by Type, 2021 (%)
- Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
Global Lung Cancer Vaccine Market Segment Percentages, by Application, 2021 (%)
- Man
- Woman
Global Lung Cancer Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Lung Cancer Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lung Cancer Vaccine revenues share in global market, 2021 (%)
Key companies Lung Cancer Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Lung Cancer Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Oncothyreon Incorporation
- Eli Lily
- ImClone Systems
- Boehringer Ingelheim
- Merck
- Ono Pharmaceutical
- CureVac
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Lung Cancer Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL LUNG CANCER VACCINE OVERALL MARKET SIZE
2.1 Global Lung Cancer Vaccine Market Size: 2021 VS 2028
2.2 Global Lung Cancer Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Lung Cancer Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Lung Cancer Vaccine Players in Global Market
3.2 Top Global Lung Cancer Vaccine Companies Ranked by Revenue
3.3 Global Lung Cancer Vaccine Revenue by Companies
3.4 Global Lung Cancer Vaccine Sales by Companies
3.5 Global Lung Cancer Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Lung Cancer Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Lung Cancer Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lung Cancer Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Lung Cancer Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Lung Cancer Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Lung Cancer Vaccine Market Size Markets, 2021 & 2028
4.1.2 Subunit Vaccines
4.1.3 Live Attenuated Vaccines
4.1.4 Conjugate Vaccines
4.1.5 Inactivated Vaccines
4.1.6 Recombinant Vector Vaccines
4.2 By Type - Global Lung Cancer Vaccine Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Lung Cancer Vaccine Sales & Forecasts
4.3.1 By Type - Global Lung Cancer Vaccine Sales, 2017-2022
4.3.2 By Type - Global Lung Cancer Vaccine Sales, 2023-2028
4.3.3 By Type - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Lung Cancer Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Lung Cancer Vaccine Market Size, 2021 & 2028
5.1.2 Man
5.1.3 Woman
5.2 By Application - Global Lung Cancer Vaccine Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Lung Cancer Vaccine Sales & Forecasts
5.3.1 By Application - Global Lung Cancer Vaccine Sales, 2017-2022
5.3.2 By Application - Global Lung Cancer Vaccine Sales, 2023-2028
5.3.3 By Application - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Lung Cancer Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Lung Cancer Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Vaccine Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Lung Cancer Vaccine Sales & Forecasts
6.3.1 By Region - Global Lung Cancer Vaccine Sales, 2017-2022
6.3.2 By Region - Global Lung Cancer Vaccine Sales, 2023-2028
6.3.3 By Region - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Lung Cancer Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Lung Cancer Vaccine Sales, 2017-2028
6.4.3 US Lung Cancer Vaccine Market Size, 2017-2028
6.4.4 Canada Lung Cancer Vaccine Market Size, 2017-2028
6.4.5 Mexico Lung Cancer Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Lung Cancer Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Lung Cancer Vaccine Sales, 2017-2028
6.5.3 Germany Lung Cancer Vaccine Market Size, 2017-2028
6.5.4 France Lung Cancer Vaccine Market Size, 2017-2028
6.5.5 U.K. Lung Cancer Vaccine Market Size, 2017-2028
6.5.6 Italy Lung Cancer Vaccine Market Size, 2017-2028
6.5.7 Russia Lung Cancer Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Lung Cancer Vaccine Market Size, 2017-2028
6.5.9 Benelux Lung Cancer Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Lung Cancer Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Lung Cancer Vaccine Sales, 2017-2028
6.6.3 China Lung Cancer Vaccine Market Size, 2017-2028
6.6.4 Japan Lung Cancer Vaccine Market Size, 2017-2028
6.6.5 South Korea Lung Cancer Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Lung Cancer Vaccine Market Size, 2017-2028
6.6.7 India Lung Cancer Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Lung Cancer Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Lung Cancer Vaccine Sales, 2017-2028
6.7.3 Brazil Lung Cancer Vaccine Market Size, 2017-2028
6.7.4 Argentina Lung Cancer Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lung Cancer Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Lung Cancer Vaccine Sales, 2017-2028
6.8.3 Turkey Lung Cancer Vaccine Market Size, 2017-2028
6.8.4 Israel Lung Cancer Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Lung Cancer Vaccine Market Size, 2017-2028
6.8.6 UAE Lung Cancer Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Lung Cancer Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Oncothyreon Incorporation
7.2.1 Oncothyreon Incorporation Corporate Summary
7.2.2 Oncothyreon Incorporation Business Overview
7.2.3 Oncothyreon Incorporation Lung Cancer Vaccine Major Product Offerings
7.2.4 Oncothyreon Incorporation Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Oncothyreon Incorporation Key News
7.3 Eli Lily
7.3.1 Eli Lily Corporate Summary
7.3.2 Eli Lily Business Overview
7.3.3 Eli Lily Lung Cancer Vaccine Major Product Offerings
7.3.4 Eli Lily Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Eli Lily Key News
7.4 ImClone Systems
7.4.1 ImClone Systems Corporate Summary
7.4.2 ImClone Systems Business Overview
7.4.3 ImClone Systems Lung Cancer Vaccine Major Product Offerings
7.4.4 ImClone Systems Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 ImClone Systems Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Lung Cancer Vaccine Major Product Offerings
7.5.4 Boehringer Ingelheim Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Boehringer Ingelheim Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Lung Cancer Vaccine Major Product Offerings
7.6.4 Merck Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Ono Pharmaceutical
7.7.1 Ono Pharmaceutical Corporate Summary
7.7.2 Ono Pharmaceutical Business Overview
7.7.3 Ono Pharmaceutical Lung Cancer Vaccine Major Product Offerings
7.7.4 Ono Pharmaceutical Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Ono Pharmaceutical Key News
7.8 CureVac
7.8.1 CureVac Corporate Summary
7.8.2 CureVac Business Overview
7.8.3 CureVac Lung Cancer Vaccine Major Product Offerings
7.8.4 CureVac Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 CureVac Key News
8 GLOBAL LUNG CANCER VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Lung Cancer Vaccine Production Capacity, 2017-2028
8.2 Lung Cancer Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Lung Cancer Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 LUNG CANCER VACCINE SUPPLY CHAIN ANALYSIS
10.1 Lung Cancer Vaccine Industry Value Chain
10.2 Lung Cancer Vaccine Upstream Market
10.3 Lung Cancer Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lung Cancer Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Lung Cancer Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL LUNG CANCER VACCINE OVERALL MARKET SIZE
2.1 Global Lung Cancer Vaccine Market Size: 2021 VS 2028
2.2 Global Lung Cancer Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Lung Cancer Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Lung Cancer Vaccine Players in Global Market
3.2 Top Global Lung Cancer Vaccine Companies Ranked by Revenue
3.3 Global Lung Cancer Vaccine Revenue by Companies
3.4 Global Lung Cancer Vaccine Sales by Companies
3.5 Global Lung Cancer Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Lung Cancer Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Lung Cancer Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lung Cancer Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Lung Cancer Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Lung Cancer Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Lung Cancer Vaccine Market Size Markets, 2021 & 2028
4.1.2 Subunit Vaccines
4.1.3 Live Attenuated Vaccines
4.1.4 Conjugate Vaccines
4.1.5 Inactivated Vaccines
4.1.6 Recombinant Vector Vaccines
4.2 By Type - Global Lung Cancer Vaccine Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Lung Cancer Vaccine Sales & Forecasts
4.3.1 By Type - Global Lung Cancer Vaccine Sales, 2017-2022
4.3.2 By Type - Global Lung Cancer Vaccine Sales, 2023-2028
4.3.3 By Type - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Lung Cancer Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Lung Cancer Vaccine Market Size, 2021 & 2028
5.1.2 Man
5.1.3 Woman
5.2 By Application - Global Lung Cancer Vaccine Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Lung Cancer Vaccine Sales & Forecasts
5.3.1 By Application - Global Lung Cancer Vaccine Sales, 2017-2022
5.3.2 By Application - Global Lung Cancer Vaccine Sales, 2023-2028
5.3.3 By Application - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Lung Cancer Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Lung Cancer Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Vaccine Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Lung Cancer Vaccine Sales & Forecasts
6.3.1 By Region - Global Lung Cancer Vaccine Sales, 2017-2022
6.3.2 By Region - Global Lung Cancer Vaccine Sales, 2023-2028
6.3.3 By Region - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Lung Cancer Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Lung Cancer Vaccine Sales, 2017-2028
6.4.3 US Lung Cancer Vaccine Market Size, 2017-2028
6.4.4 Canada Lung Cancer Vaccine Market Size, 2017-2028
6.4.5 Mexico Lung Cancer Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Lung Cancer Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Lung Cancer Vaccine Sales, 2017-2028
6.5.3 Germany Lung Cancer Vaccine Market Size, 2017-2028
6.5.4 France Lung Cancer Vaccine Market Size, 2017-2028
6.5.5 U.K. Lung Cancer Vaccine Market Size, 2017-2028
6.5.6 Italy Lung Cancer Vaccine Market Size, 2017-2028
6.5.7 Russia Lung Cancer Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Lung Cancer Vaccine Market Size, 2017-2028
6.5.9 Benelux Lung Cancer Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Lung Cancer Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Lung Cancer Vaccine Sales, 2017-2028
6.6.3 China Lung Cancer Vaccine Market Size, 2017-2028
6.6.4 Japan Lung Cancer Vaccine Market Size, 2017-2028
6.6.5 South Korea Lung Cancer Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Lung Cancer Vaccine Market Size, 2017-2028
6.6.7 India Lung Cancer Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Lung Cancer Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Lung Cancer Vaccine Sales, 2017-2028
6.7.3 Brazil Lung Cancer Vaccine Market Size, 2017-2028
6.7.4 Argentina Lung Cancer Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lung Cancer Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Lung Cancer Vaccine Sales, 2017-2028
6.8.3 Turkey Lung Cancer Vaccine Market Size, 2017-2028
6.8.4 Israel Lung Cancer Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Lung Cancer Vaccine Market Size, 2017-2028
6.8.6 UAE Lung Cancer Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Lung Cancer Vaccine Major Product Offerings
7.1.4 GlaxoSmithKline Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Oncothyreon Incorporation
7.2.1 Oncothyreon Incorporation Corporate Summary
7.2.2 Oncothyreon Incorporation Business Overview
7.2.3 Oncothyreon Incorporation Lung Cancer Vaccine Major Product Offerings
7.2.4 Oncothyreon Incorporation Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Oncothyreon Incorporation Key News
7.3 Eli Lily
7.3.1 Eli Lily Corporate Summary
7.3.2 Eli Lily Business Overview
7.3.3 Eli Lily Lung Cancer Vaccine Major Product Offerings
7.3.4 Eli Lily Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Eli Lily Key News
7.4 ImClone Systems
7.4.1 ImClone Systems Corporate Summary
7.4.2 ImClone Systems Business Overview
7.4.3 ImClone Systems Lung Cancer Vaccine Major Product Offerings
7.4.4 ImClone Systems Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 ImClone Systems Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Lung Cancer Vaccine Major Product Offerings
7.5.4 Boehringer Ingelheim Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Boehringer Ingelheim Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Lung Cancer Vaccine Major Product Offerings
7.6.4 Merck Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Ono Pharmaceutical
7.7.1 Ono Pharmaceutical Corporate Summary
7.7.2 Ono Pharmaceutical Business Overview
7.7.3 Ono Pharmaceutical Lung Cancer Vaccine Major Product Offerings
7.7.4 Ono Pharmaceutical Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Ono Pharmaceutical Key News
7.8 CureVac
7.8.1 CureVac Corporate Summary
7.8.2 CureVac Business Overview
7.8.3 CureVac Lung Cancer Vaccine Major Product Offerings
7.8.4 CureVac Lung Cancer Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 CureVac Key News
8 GLOBAL LUNG CANCER VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Lung Cancer Vaccine Production Capacity, 2017-2028
8.2 Lung Cancer Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Lung Cancer Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 LUNG CANCER VACCINE SUPPLY CHAIN ANALYSIS
10.1 Lung Cancer Vaccine Industry Value Chain
10.2 Lung Cancer Vaccine Upstream Market
10.3 Lung Cancer Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lung Cancer Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Lung Cancer Vaccine in Global Market
Table 2. Top Lung Cancer Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Lung Cancer Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Lung Cancer Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Lung Cancer Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Lung Cancer Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Lung Cancer Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Lung Cancer Vaccine Product Type
Table 9. List of Global Tier 1 Lung Cancer Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lung Cancer Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Lung Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Lung Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Lung Cancer Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Lung Cancer Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Lung Cancer Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Lung Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Lung Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Lung Cancer Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Lung Cancer Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Lung Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Lung Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Lung Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Lung Cancer Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Lung Cancer Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Lung Cancer Vaccine Product Offerings
Table 48. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Oncothyreon Incorporation Corporate Summary
Table 50. Oncothyreon Incorporation Lung Cancer Vaccine Product Offerings
Table 51. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Eli Lily Corporate Summary
Table 53. Eli Lily Lung Cancer Vaccine Product Offerings
Table 54. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. ImClone Systems Corporate Summary
Table 56. ImClone Systems Lung Cancer Vaccine Product Offerings
Table 57. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Boehringer Ingelheim Corporate Summary
Table 59. Boehringer Ingelheim Lung Cancer Vaccine Product Offerings
Table 60. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Lung Cancer Vaccine Product Offerings
Table 63. Merck Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Ono Pharmaceutical Corporate Summary
Table 65. Ono Pharmaceutical Lung Cancer Vaccine Product Offerings
Table 66. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CureVac Corporate Summary
Table 68. CureVac Lung Cancer Vaccine Product Offerings
Table 69. CureVac Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Lung Cancer Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Lung Cancer Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Lung Cancer Vaccine Production by Region, 2017-2022 (K Units)
Table 73. Global Lung Cancer Vaccine Production by Region, 2023-2028 (K Units)
Table 74. Lung Cancer Vaccine Market Opportunities & Trends in Global Market
Table 75. Lung Cancer Vaccine Market Drivers in Global Market
Table 76. Lung Cancer Vaccine Market Restraints in Global Market
Table 77. Lung Cancer Vaccine Raw Materials
Table 78. Lung Cancer Vaccine Raw Materials Suppliers in Global Market
Table 79. Typical Lung Cancer Vaccine Downstream
Table 80. Lung Cancer Vaccine Downstream Clients in Global Market
Table 81. Lung Cancer Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Lung Cancer Vaccine in Global Market
Table 2. Top Lung Cancer Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Lung Cancer Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Lung Cancer Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Lung Cancer Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Lung Cancer Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Lung Cancer Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Lung Cancer Vaccine Product Type
Table 9. List of Global Tier 1 Lung Cancer Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lung Cancer Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Lung Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Lung Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Lung Cancer Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Lung Cancer Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Lung Cancer Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Lung Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Lung Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Lung Cancer Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Lung Cancer Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Lung Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Lung Cancer Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Lung Cancer Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Lung Cancer Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Lung Cancer Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Lung Cancer Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Lung Cancer Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Lung Cancer Vaccine Sales, (K Units), 2023-2028
Table 46. GlaxoSmithKline Corporate Summary
Table 47. GlaxoSmithKline Lung Cancer Vaccine Product Offerings
Table 48. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Oncothyreon Incorporation Corporate Summary
Table 50. Oncothyreon Incorporation Lung Cancer Vaccine Product Offerings
Table 51. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Eli Lily Corporate Summary
Table 53. Eli Lily Lung Cancer Vaccine Product Offerings
Table 54. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. ImClone Systems Corporate Summary
Table 56. ImClone Systems Lung Cancer Vaccine Product Offerings
Table 57. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Boehringer Ingelheim Corporate Summary
Table 59. Boehringer Ingelheim Lung Cancer Vaccine Product Offerings
Table 60. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Lung Cancer Vaccine Product Offerings
Table 63. Merck Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Ono Pharmaceutical Corporate Summary
Table 65. Ono Pharmaceutical Lung Cancer Vaccine Product Offerings
Table 66. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CureVac Corporate Summary
Table 68. CureVac Lung Cancer Vaccine Product Offerings
Table 69. CureVac Lung Cancer Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Lung Cancer Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Lung Cancer Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Lung Cancer Vaccine Production by Region, 2017-2022 (K Units)
Table 73. Global Lung Cancer Vaccine Production by Region, 2023-2028 (K Units)
Table 74. Lung Cancer Vaccine Market Opportunities & Trends in Global Market
Table 75. Lung Cancer Vaccine Market Drivers in Global Market
Table 76. Lung Cancer Vaccine Market Restraints in Global Market
Table 77. Lung Cancer Vaccine Raw Materials
Table 78. Lung Cancer Vaccine Raw Materials Suppliers in Global Market
Table 79. Typical Lung Cancer Vaccine Downstream
Table 80. Lung Cancer Vaccine Downstream Clients in Global Market
Table 81. Lung Cancer Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Lung Cancer Vaccine Segment by Type
Figure 2. Lung Cancer Vaccine Segment by Application
Figure 3. Global Lung Cancer Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Lung Cancer Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lung Cancer Vaccine Revenue in 2021
Figure 9. By Type - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Lung Cancer Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Lung Cancer Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 19. US Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 33. China Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Lung Cancer Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Lung Cancer Vaccine by Region, 2021 VS 2028
Figure 50. Lung Cancer Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Lung Cancer Vaccine Segment by Type
Figure 2. Lung Cancer Vaccine Segment by Application
Figure 3. Global Lung Cancer Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Lung Cancer Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lung Cancer Vaccine Revenue in 2021
Figure 9. By Type - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Lung Cancer Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Lung Cancer Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 19. US Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 33. China Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Lung Cancer Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Lung Cancer Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Lung Cancer Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Lung Cancer Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Lung Cancer Vaccine by Region, 2021 VS 2028
Figure 50. Lung Cancer Vaccine Industry Value Chain
Figure 51. Marketing Channels
